| Literature DB >> 35630428 |
Sarah K Giles1, Uwe H Stroeher1,2, Bhavya Papudeshi1, Robert A Edwards1, Jessica Ap Carlson-Jones1, Michael Roach1, Melissa H Brown1.
Abstract
Acinetobacter baumannii is an opportunistic human pathogen responsible for numerous severe nosocomial infections. Genome analysis on the A. baumannii clinical isolate 04117201 revealed the presence of 13 two-component signal transduction systems (TCS). Of these, we examined the putative TCS named here as StkSR. The stkR response regulator was deleted via homologous recombination and its progeny, ΔstkR, was phenotypically characterized. Antibiogram analyses of ΔstkR cells revealed a two-fold increase in resistance to the clinically relevant polymyxins, colistin and polymyxin B, compared to wildtype. PAGE-separation of silver stained purified lipooligosaccharide isolated from ΔstkR and wildtype cells ruled out the complete loss of lipooligosaccharide as the mechanism of colistin resistance identified for ΔstkR. Hydrophobicity analysis identified a phenotypical change of the bacterial cells when exposed to colistin. Transcriptional profiling revealed a significant up-regulation of the pmrCAB operon in ΔstkR compared to the parent, associating these two TCS and colistin resistance. These results reveal that there are multiple levels of regulation affecting colistin resistance; the suggested 'cross-talk' between the StkSR and PmrAB two-component systems highlights the complexity of these systems.Entities:
Keywords: TCS; adherence; antibiotic resistance; hydrophobicity; lipid A; phosphoethanolamine; pmrCAB
Year: 2022 PMID: 35630428 PMCID: PMC9146086 DOI: 10.3390/microorganisms10050985
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Cell adherence capacity of A. baumannii clinical strains to A549 pneumocytes. The CFU/well values of 11 A. baumannii strains were examined after exposure to A549 cells. Bars indicate the standard error of three separate experiments. Assessments of skewness, kurtosis and the Shapiro–Wilk normality test were undertaken. *** represents a p-value of < 0.001 as determined by an analysis of variance test, between ATCC 17978 and the clinical isolate.
Antimicrobial resistance profiles of Acinetobacter baumannii clinical strains.
| Compound | ATCC 17978 | 04117201 | 1172312 | WM98 | 08315000 | 04397670 | 9030751 | 1077697 | 9038266 | 08325050 | 083217005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KAN | R | R | R | S | S | R | R | S | R | S | R |
| ERY | S | S | S | S | R | S | S | I | S | I | R |
| TET | S | R | R | I | R | I | R | I | R | R | R |
| AMP | 250 | >500 | >500 | 250 | >500 | >500 | >500 | >500 | >500 | >500 | >500 |
| CIP | 3.25 | 30 | 30 | 3.25 | >240 | 60 | 60 | 60 | 60 | >240 | >240 |
| CST | 4 | 8 | 8 | 16 | 8 | 8 | 32 | 32 | 16 | 4 | 4 |
| TEL | 0.93 | 1.87 | 1.87 | 1.87 | 3.75 | 3.75 | 1.87 | 1.87 | 3.75 | 3.75 | 3.75 |
| GEN | 32 | 500 | 500 | 16 | 125 | 250 | 125 | 125 | 250 | 125 | 125 |
| PMB | 8 | 16 | 16 | 16 | 8 | 16 | 32 | 32 | 8 | 8 | 8 |
| RIF | 8 | 8 | 8 | 8 | >64 | 4 | 4 | 4 | 4 | 4 | 4 |
| H2O2
| 125 | 250 | 250 | 500 | 250 | 125 | 250 | 250 | 250 | 125 | 250 |
KAN, kanamycin; ERY, erythromycin; TET, tetracycline; AMP, ampicillin; CIP, ciprofloxacin; CST, colistin; TEL, tellurite; GEN, gentamicin; PMB, polymyxin B; RIF, rifampicin; H2O2, hydrogen peroxide. (µg/mL). R, Resistant; I, Intermediate; S, Susceptible; determined by Kirby Bauer against the CLSI standards. (nM).
Response regulators identified in the clinical Acinetobacter baumannii 04117201.
| Peg # in 04117201 | Location in 04117201 | A1S + # in ATCC 17978 | Location in ATCC 17978 | Present in SDF | Response Regulator | Description |
|---|---|---|---|---|---|---|
| 25 | 18192–18935 | A1S_1753 | 2038890–2044193 | N | AdeR | TCS, known as AdeRS, involved in antibiotic resistance and AdeABC efflux pump [ |
| 95 | 40498–39824 | A1S_2751 | 3193938- 3189264 | Y | PmrA | TCS, known as PmrAB involved in lipid A modification [ |
| 226 | 180539–179853 | A1S_2883 | 3334601–3333044 | Y | BaeR | TCS known as BaeRS involved in chemical transport and regulation+ of AdeABC and AdeIJK pumps [ |
| 519 | 97888–98604 | A1S_2137 | 2497340–2492622 | Y | KdpE | TCS, known as KdpED involved in potassium transport [ |
| 838 | 118775–122230 | A1S_1394 | 1636507–1641464 | N | StkR | TCS known as GerE (renamed here as StkSR) |
| 1104 | 21883–21119 | A1S_3229 | 3720752–3725517 | Y | OmpR | TCS, EnvZ-OmpR, involved in osmotic stress [ |
| 1270 | 84347–85009 | A1S_2288 | 2655031–2650369 | Y | QseB | TCS, known as QseBC involved in biofilm formation [ |
| 1649 | 134448–135158 | A1S_3375 | 3881425–3886134 | Y | PhoB | TCS, known as PhoRB involved in phosphate stress and quorum sensing [ |
| 1825 | 90896–91486 | A1S_2006 | 2319938–2324522 | N | NasT | Orphan response regulator known as NasT; no histidine kinase identifiable up or down stream |
| 1962 | 98859–99575 | A1S_0748 | 887026–892617 | Y | RstA | TCS, known as BfmR involved in biofilm formation [ |
| 2189 | 37589–36954 | A1S_0233 | 259526–264163 | N | PilR | TCS, known as PilR involved in Type 4 fimbriae expression [ |
| 2213 | 62365–63105 | A1S_0261 | 284993–289733 | Y | AlgB | TCS, known as AlgBZ involved in alginate biosynthesis [ |
| 2465 | 1290–2258 | A1S_0621 | 670111–674210 | N | RsbU | Orphan response regulator known as RsbU; no histidine kinase identifiable up or down stream [ |
Annotated by Rapid Annotation using subsystem technology (RAST) https://rast.nmpdr.org/ (accessed on 15 March 2015). Locus tag number.
Antimicrobial resistance profile of the Acinetobacter baumannii 04117201 and ΔstkR mutant.
| Compound | WT (µg/mL) | Δ | Antibiotic Family Group |
|---|---|---|---|
| Novobiocin | 31 | 31 | Aminocoumaria |
| Amikacin | 10 | 10 | Aminoglycoside |
| Gentamicin | 500 | 500 | Aminoglycoside |
| Kanamycin | 3000 | >3000 | Aminoglycoside |
| Streptomycin | >300 | >300 | Aminoglycoside |
| Chloramphenicol; | 5 | 5–10 | Amphenicol |
| Rifampicin | 4 | 4–8 | Ansamycins |
| Ampicillin | >500 | >500 | Beta-lactam |
| Ciprofloxacin | 30 | 30 | Carboxy fluoroquinoline |
| Chlorhexidine | 7.5–15 | 15 | Chlorobenzenes |
| Triclosan | 0.15–0.65 | 0.31–0.65 | Diphenyl ethers |
| Tellurite | 1.87 | 1.87 | Metal |
| Triton X100 | 64 | 64 | Nonionic surfactant |
| Pentamidine | 125 | 125 | Phenol ether |
| Colistin | 8 | 16 | Polymyxin |
| Polymyxin | 16 | 32 | Polymyxin |
| Nalidixic acid | 1250 | 1250 | Quinolone |
Figure 2Cell surface hydrophobicity of A. baumannii 04117201 and ΔstkR mutant. Cell surface hydrophobicity was assessed by the cells’ affiliation to xylene. A. baumannii strain 04117201 (WT) is without colistin exposure, WT + is with exposure to 3 μg/mL of colistin. A. baumannii 04117201 ΔstkR mutant is without colistin exposure, ΔstkR+ is with exposure to 3 μg/mL of colistin. Bars represent the standard deviation of three separate experiments. A Kruskal–Wallis test was performed to compare the means of the WT and ΔstkR mutant with and without colistin exposure. *** represents a p-value < 0.001 and ** represents a p-value of <0.01 as established by an analysis of variance test.
Figure 3Membrane perturbation of A. baumannii 04117201 (WT) and ΔstkR mutant after colistin stress. WT and ΔsktR mutant strains were subjected to sub-MIC and MIC levels of colistin (3 μg/mL and 12 μg/mL) and cross-sections were examined by TEM (60,000× magnification); 200 nm scale is shown in white. Images are of (A) WT, (B) ΔsktR, (C) WT after exposure to 3 μg/mL colistin, (D) ΔstkR after exposure to 3 μg/mL of colistin, (E) WT after exposure to 12 μg/mL colistin, and (F) ΔstkR after exposure to 12 μg/mL colistin; arrows show membrane perturbation and/or leakage of cellular contents.
Figure 4Lipooligosaccharide analysis of the 04117201 (WT) and ΔstkR mutant. The lipid A and O-antigen components of the strains’ membrane was resolved on a 15% polyacrylamide gel and silver stained. (A) control lipopolysaccharide from Pseudomonas aeruginosa PA01 showing the presence of O-antigen; (B) WT, and (C) ΔstkR. Brackets identify either the lipid A core or O-antigen regions.
Single nucleotide polymorphisms regions identified in the ΔstkR mutant compared to the WT strain.
| SNP Position | Codon in WT | Codon in Δ | Amino Acid in WT | Amino Acid in Δ | Annotation of Region |
|---|---|---|---|---|---|
| 176528 | - | - | - | - | Non-coding region |
| 538323 | GAG | GGG | Glu | Gly | Hypothetical protein (Repeat region) |
| 1001055 | - | - | - | - | Non-coding region |
| 1058011 | - | - | - | - | Non-coding region |
| 1098529 | - | - | - | - | Non-coding region |
| 1150782 | TAA | CAA | Stop | Gln | Aldehyde dehydrogenase |
| 1590889 | GCT | GCC | Ala | Ala | Hypothetical protein |
| 2730447 | TTT | TTC | Phe | Phe | Hypothetical protein |
| 2796261 | - | - | - | - | Non-coding region |
| 3132365 | TTC | TCC | Phe | Ser | Phenazine biosynthesis protein (PhzF) |
| 3201037 | CCC | TCC | Pro | Ser | Repeat region |
| 3361708 | - | - | - | - | Non-coding region |
| 3370031 | - | - | - | - | Non-coding region |
| 3445432 | AAA | GAA | Lys | Glu | Alcyl-CoA Dehydrogenase |
SNP positions identified with SAMtools v1.9 and VCFools v0.11.17. Annotation of region undertaken using Prokka.